Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs HCTZ in Essential Hypertension
NCT00219154Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Mar 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00219154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219154.